Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1926
UL Solutions
ULS
$16.2B
| $6M | ﹤0.01% |
91,454
+77,499
| +555% | +$6.07M |
2024 Q2
9 quarters
|
|
1927
PUT
Celestica
CLS
$30.3B
| $6M | ﹤0.01% |
+16,600
| New | +$5.49M |
2026 Q3
0 quarters
|
|
1928
AMN Healthcare
AMN
$1.47B
| $5.99M | ﹤0.01% |
167,060
+160,527
| +2,457% | +$5.46M |
2013 Q2
53 quarters
|
|
1929
CALL
Abbott
ABT
$188B
| $5.99M | ﹤0.01% |
+60,600
| New | +$6.33M |
2026 Q3
0 quarters
|
|
1930
SFL Corp
SFL
$1.72B
| $5.97M | ﹤0.01% |
453,724
-59,479
| -12% | -$724K |
2022 Q1
18 quarters
|
|
1931
CALL
Blackstone
BX
$95B
| $5.95M | ﹤0.01% |
53,100
+43,600
| +459% | +$5.7M |
2025 Q3
4 quarters
|
|
1932
Lumen Technologies, Inc. Common Stock
LUMN
$4.22B
| $5.95M | ﹤0.01% |
1,062,680
+741,024
| +230% | +$4.73M |
2022 Q1
18 quarters
|
|
1933
Synaptics
SYNA
$4.69B
| $5.95M | ﹤0.01% |
58,653
+43,536
| +288% | +$4.6M |
2013 Q2
53 quarters
|
|
1934
i-80 Gold Corp
IAUX
$1.12B
| $5.94M | ﹤0.01% |
3,576,258
+1,615,315
| +82% | +$2.57M |
2022 Q2
17 quarters
|
|
1935
Aris Mining
ARIS
$3.05B
| $5.91M | ﹤0.01% |
339,926
+193,847
| +133% | +$3.35M |
2023 Q3
12 quarters
|
|
1936
Telephone and Data Systems
TDS
$3.43B
| $5.9M | ﹤0.01% |
173,946
+1,893
| +1% | +$66.2K |
2013 Q2
53 quarters
|
|
1937
Deluxe
DLX
$1.23B
| $5.89M | ﹤0.01% |
256,352
+235,843
| +1,150% | +$5.79M |
2013 Q2
53 quarters
|
|
1938
Scansource
SCSC
$910M
| $5.87M | ﹤0.01% |
100,021
+66,244
| +196% | +$3.68M |
2013 Q2
53 quarters
|
|
1939
PUT
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $5.87M | ﹤0.01% |
99,000
-800
| -0.8% | -$47.8K |
2026 Q2
1 quarter
|
|
1940
Surgery Partners
SGRY
$3.53B
| $5.87M | ﹤0.01% |
423,048
+400,190
| +1,751% | +$6M |
2015 Q4
43 quarters
|
|
1941
Canadian Solar
CSIQ
$671M
| $5.86M | ﹤0.01% |
509,082
-88,366
| -15% | -$1.23M |
2021 Q3
20 quarters
|
|
1942
Amylyx Pharmaceuticals
AMLX
$3.89B
| $5.85M | ﹤0.01% |
201,151
+144,893
| +258% | +$3.84M |
2022 Q1
18 quarters
|
|
1943
Postal Realty Trust
PSTL
$749M
| $5.8M | ﹤0.01% |
253,607
+143,289
| +130% | +$3.38M |
2022 Q1
18 quarters
|
|
1944
ProPetro Holding
PUMP
$923M
| $5.78M | ﹤0.01% |
653,749
+116,887
| +22% | +$1.34M |
2017 Q1
38 quarters
|
|
1945
Cinemark Holdings
CNK
$4.73B
| $5.77M | ﹤0.01% |
154,745
+128,970
| +500% | +$4.49M |
2013 Q2
53 quarters
|
|
1946
Seaboard Corp
SEB
$3.59B
| $5.77M | ﹤0.01% |
1,462
-1,442
| -50% | -$6.24M |
2020 Q2
25 quarters
|
|
1947
CALL
iShares Biotechnology ETF
IBB
$11.1B
| $5.77M | ﹤0.01% |
27,400
| – | – |
2026 Q1
2 quarters
|
|
1948
Impinj
PI
$5.2B
| $5.77M | ﹤0.01% |
32,164
+25,008
| +349% | +$4.04M |
2016 Q3
40 quarters
|
|
1949
Liquidia Corp
LQDA
$5.17B
| $5.77M | ﹤0.01% |
190,516
+59,653
| +46% | +$4.49M |
2022 Q2
17 quarters
|
|
1950
Woodside Energy
WDS
$40.1B
| $5.76M | ﹤0.01% |
260,030
-111,184
| -30% | -$2.5M |
2025 Q4
3 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.